Pregnancy outcome in carriers of fragile X

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 8, 2000, Pages 969-972

  Kallinen, Juuso ^a   Korhonen, Kati ^a   Kortelainen, Saara ^a   Heinonen, Seppo ^a   Ryynänen, Markku ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; FETUS DEATH; FETUS DISTRESS; FRAGILE X SYNDROME; GENETIC COUNSELING; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURITY; PRIORITY JOURNAL; SMALL FOR DATE INFANT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; FRAGILE X SYNDROME; HETEROZYGOTE; HUMANS; LOGISTIC MODELS; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; X CHROMOSOME;

EID: 0033943162     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb10398.x     Document Type: Article

References (14)

1. Sherman S. Epidemiology in fragile X syndrome. In: Hagerman RJ, Sylverman AC, editors. Diagnosis, Treatment, and Research. Baltimore: Johns Hopkins University Press, 1991: 69–86.
2. De Vries BB, Wiegers AM, Smits AP et al. Mental status of females with an FMR1 gene full mutation. Am J Hum Genet 1996; 58: 1025–1032.
3. Turner G, Robinson H, Laing S, Purvis-Smith S. Preventive screening for the fragile X syndrome. N Engl J Med 1986; 315: 607–609.
4. Verkerk AJMH, Pieretti M, Sutcliffe J et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile × syndrome. Cell 1991; 65: 905–914.
5. Fu Y-H, Kuhl DPA, Pizzutti A et al. Fragile-X: a polymorphic and highly mutable CGG repeat in the FMR-1 gene. Cell 1991; 67: 1047–1058.
6. Reiss AL, Kazazian H Jr, Krebs CM et al. Frequency and stability of the fragile X premutation. Hum Mol Genet 1994; 3: 393–398.
7. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. Prevalence of carriers of pre-mutation size alleles of the FMR1 gene and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 1995; 57: 1006–1018.
8. Franke P, Maier W, Hautzinger M et al. Fragile-X carrier females: evidence for a distinct psychopathological phenotype Am J Med Genet 1996; 64: 334–339.
9. Hull C, Hagerman R. A study of the physical behavioural, and medical phenotype, including anthropometric measures, of females with fragile X syndrome. Am J Dis Child 1993; 147: 1236–1241.
10. Schwartz CE, Dean J, Howard-Peebles PN et al. Obstetrical and gynaecological complications in fragile X carriers: a multicenter study. Am J Med Genet 1994; 51: 400–402.
11. Partington MW, Moore DY, Turner GM. Confirmation of early menopause in fragile X carriers. Am J Med Genet 1996; 64: 370–372.
12. Kenneson A, Cramer DW, Warren ST. Fragile X permutations are not a major cause of early menopause. Am J Hum Genet 1997; 61: 1362–1369.
13. Ryynänen M, Heinonen S, Makkonen M, Kajanoja E, Mannermaa A, Kirkinen P. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. Eur J Hum Genet 1999; 7: 212–216.
14. Ryynänen M, Kirkinen P, Mannermaa A, Saarikoski S. Carrier diagnosis of the fragile X syndrome—a challenge in antenatal clinics. Am J Obst Gynecol 1995; 172: 1236–1239.